These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2658559)

  • 1. Selection of ESRD treatment: an international study.
    Mattern WD; McGaghie WC; Rigby RJ; Nissenson AR; Dunham CB; Khayrallah MA
    Am J Kidney Dis; 1989 Jun; 13(6):457-64. PubMed ID: 2658559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preferences of nephrologists among end-stage renal disease treatment options.
    Dunham C; Mattern WD; McGaghie WC
    Am J Nephrol; 1985; 5(6):470-5. PubMed ID: 3909822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient education and access of ESRD patients to renal replacement therapies beyond in-center hemodialysis.
    Mehrotra R; Marsh D; Vonesh E; Peters V; Nissenson A
    Kidney Int; 2005 Jul; 68(1):378-90. PubMed ID: 15954930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [REIN Report 2011--summary].
    Couchoud C; Lassalle M; Jacquelinet C
    Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of patient- and center-level characteristics on uptake of home dialysis in Australia and New Zealand: a multicenter registry analysis.
    Ethier I; Cho Y; Hawley C; Pascoe EM; Roberts MA; Semple D; Nadeau-Fredette AC; Sypek MP; Viecelli A; Campbell S; van Eps C; Isbel NM; Johnson DW
    Nephrol Dial Transplant; 2020 Nov; 35(11):1938-1949. PubMed ID: 32031636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case-mix and treatment in end-stage renal disease: hemodialysis v peritoneal dialysis.
    Radecki SE; Mendenhall RC; Nissenson AR; Freeman RB; Blagg CR; Capelli JP; Gentile DE; Feinstein EI
    Am J Kidney Dis; 1988 Jan; 11(1):7-14. PubMed ID: 3122560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantity and quality of ESRD treatment in the United States of America.
    Sadler J
    Contrib Nephrol; 1990; 78():181-5. PubMed ID: 2225835
    [No Abstract]   [Full Text] [Related]  

  • 8. ESRD in Australia and New Zealand at the end of the millennium: a report from the ANZDATA registry.
    McDonald SP; Russ GR; Kerr PG; Collins JF;
    Am J Kidney Dis; 2002 Dec; 40(6):1122-31. PubMed ID: 12460029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality differences between hemodialysis and peritoneal dialysis among ESRD patients in Georgia.
    Tchokhonelidze I
    Georgian Med News; 2007 Feb; (143):27-30. PubMed ID: 17404434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of peritoneal dialysis in the era of the resurgence of home hemodialysis.
    Burkart J
    Hemodial Int; 2008 Jul; 12 Suppl 1():S51-4. PubMed ID: 18638242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Switching and the definition of modality in end-stage renal disease treatment.
    Smith DG; Wheeler JR
    Med Care; 1987 Dec; 25(12):1168-78. PubMed ID: 3320593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal Changes in Mortality Risk by Dialysis Modality in the Australian and New Zealand Dialysis Population.
    Marshall MR; Polkinghorne KR; Kerr PG; Agar JW; Hawley CM; McDonald SP
    Am J Kidney Dis; 2015 Sep; 66(3):489-98. PubMed ID: 25958081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality, Hospitalization, and Technique Failure in Daily Home Hemodialysis and Matched Peritoneal Dialysis Patients: A Matched Cohort Study.
    Weinhandl ED; Gilbertson DT; Collins AJ
    Am J Kidney Dis; 2016 Jan; 67(1):98-110. PubMed ID: 26319755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short and long nightly hemodialysis in the United States.
    Lockridge RS; Pipkin M
    Hemodial Int; 2008 Jul; 12 Suppl 1():S48-50. PubMed ID: 18638241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What do American nephologists think about dialysis modality selection?
    Mendelssohn DC; Mullaney SR; Jung B; Blake PG; Mehta RL
    Am J Kidney Dis; 2001 Jan; 37(1):22-29. PubMed ID: 11136163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Home dialysis and dialysis treatment modalities in the VA system.
    Wiegmann TB; Blumenkrantz M; Layard M; Schmidt RW; Shen F; Stead W
    Am J Kidney Dis; 1983 Jul; 3(1):32-6. PubMed ID: 6346865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demography and survival of patients receiving treatment for chronic renal failure in Australia and New Zealand: report on dialysis and renal transplantation treatment from the Australia and New Zealand Dialysis and Transplant Registry.
    Disney AP
    Am J Kidney Dis; 1995 Jan; 25(1):165-75. PubMed ID: 7810521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensive Hemodialysis and Mortality Risk in Australian and New Zealand Populations.
    Marshall MR; Polkinghorne KR; Kerr PG; Hawley CM; Agar JW; McDonald SP
    Am J Kidney Dis; 2016 Apr; 67(4):617-28. PubMed ID: 26561355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment bias in the management of end-stage renal disease.
    Smith MD; Hong BA; Michelman JE; Robson AM
    Am J Kidney Dis; 1983 Jul; 3(1):21-6. PubMed ID: 6346863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost analysis of dialysis treatments for end-stage renal disease (ESRD).
    Goeree R; Manalich J; Grootendorst P; Beecroft ML; Churchill DN
    Clin Invest Med; 1995 Dec; 18(6):455-64. PubMed ID: 8714789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.